Biomea Fusion
Phase 2Our mission is to revolutionize medicine by creating therapies that cure patients of their disease. - Biomea Fusion
Market Cap
Private
Pipeline
—
Patents
—
Publications
—
Private Company
Total funding raised: $431M
About
Our mission is to revolutionize medicine by creating therapies that cure patients of their disease. - Biomea Fusion
Small Molecules
Funding History
6Total raised:$431M
Series B$106MDec 15, 2021
IPO$120MOct 15, 2021
Series B$45MMar 15, 2021
IPO$100MFeb 11, 2021